$14.95
0.140.95%
近くで: Sep 25, 5:00 PM EST
$14.95
0.140.95%
プレマーケット: 8:06 AM EST
Benzinga
Benzinga
Benzinga
火曜日, 9 29
Cullinan Therapeutics Inc
CGEMNASDAQ
Cullinan Therapeutics Earnings & Forecasts
Cullinan Therapeutics (CGEM) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
Cullinan Therapeutics Guidance
Recent Earnings Results
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-0.82 | $-0.84 | $-0.82 | $-0.92 |
| Actual | $-0.81 | $-0.75 | $-0.77 | $-0.77 |
| Surprise | +1.22% | +10.7% | +6.10% | +16.3% |
| Revenue | ||||
| Estimate | $7.0M | $3.5M | $9.9M | — |
| Actual | $0 | $0 | — | — |
| Surprise | -100.0% | -100.0% | -100.0% | — |
Analyst Estimates — Forward PeriodsSource: Wall Street consensus
| Metric | Q3 '26E | Q4 '26E | Q1 '27E | Q2 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $-0.83 | $-0.71 | $-0.52 | $-0.66 |
| Revenue | ||||
| Consensus | $402000 | $16.2M | — | — |
Earnings & Guidance News
Benzinga
© 2026 Benzinga | All Rights Reserved